Ranking results:

Past rankings:

2019
Criterium:	Position:
Overall Score:	> 1000
Total Project Funding per Partner:	> 1000
Total Number of Projects:	> 1000
2016
Criterium:	Position:
Overall Score:	> 1000
Networking Rank (Reputation):	> 1000

Ranking timeline:

Project Participation Performance(2016-01-01 - 2025-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0^*

^*Ratio includes only projects with > 2 partners

Summary:

	Total project funding [€]:			Projects [No]:
Year:	coordinator^*	participant^*	per partner	as coordinator	as participant
2019	0	3.459.053	470.625		1
2016	0	4.666.400	589.234		1

^*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:	Projects [No]:
FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO	1
FUNDACIO INSTITUT DE BIOENGINYERIA DE CATALUNYA	1
INSPHERO	1
JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT	1
JOHANN WOLFGANG GOETHEUNIVERSITATFRANKFURT AM MAIN	1
LONZA NETHERLANDS BV	1
MYCRONIC AB	1
PROSCIENCIA BERATUNGSGMBH	1
SPARKS & CO	1
TECHNION ISRAEL INSTITUTE OF TECHNOLOGY	1
THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE	1

Constancy:

Total number of partners: 11
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 11
Frequent / Rare Partner Ratio: 0

Project overview:

Start date	Project	acronym	role	funding	partners
2019-07-01	BIOPRINTING BY LIGHT-SHEET LITHOGRAPHY: ENGINEERING COMPLEX TISSUES WITH HIGH RESOLUTION AT HIGH SPEED	BRIGHTER	participant	3.459.053	5
2016-01-01	Production and characterization of endocrine cells derived from human pancreas organoids for the cell-based therapy of type 1 diabetes	LSFM4LIFE	participant	4.666.400	8

CELLENDES GMBH - Germany